| Hang Seng Index | 25.280 HKD | +0.080 | +0.317% | 297.33M | 7.50B | 25.231 (+0.195%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 5.400 HKD | +0.030 | +0.559% | 388.55M | 2.10B | 5.386 (+0.266%) HKD as at 2025/08/04 | | |
| Hang Seng China Enterprises | 91.100 HKD | +0.120 | +0.132% | 17.06M | 1.55B | 91.032 (+0.075%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.425 HKD | +0.035 | +0.649% | 74.74M | 405.60M | 5.419 (+0.105%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.584 HKD | -0.012 | -0.752% | 105.27M | 166.86M | 1.590 (-0.371%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.580 HKD | +0.025 | +0.450% | 16.56M | 92.22M | 5.561 (+0.343%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.068 HKD | -0.010 | -0.481% | 44.17M | 91.56M | 2.076 (-0.361%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 11.590 HKD | +0.060 | +0.520% | 5.45M | 63.07M | 11.375 (+1.891%) HKD as at 2025/08/01 | | |
| Hang Seng TECH Index | 5.485 HKD | +0.025 | +0.458% | 9.75M | 53.50M | 5.469 (+0.300%) HKD as at 2025/08/04 | | |
| Hang Seng China Enterprises | 10.560 HKD | +0.020 | +0.190% | 4.48M | 47.22M | 10.418 (+1.361%) HKD as at 2025/08/01 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.740 HKD | +0.430 | +2.636% | 1.86M | 30.80M | 16.374 (+2.233%) HKD as at 2025/08/04 | | |
| FTSE US Treasury 20+ Years Index | 69.020 HKD | +0.620 | +0.906% | 285.09K | 19.68M | 68.854 (+0.241%) HKD as at 2025/08/01 | | |
| FTSE China A50 | 14.780 HKD | +0.100 | +0.681% | 1.14M | 16.85M | 14.610 (+1.165%) HKD as at 2025/08/01 | | |
| London Gold Fixing Price | 2,440.000 HKD | +12.000 | +0.494% | 6.56K | 16.02M | N/A | | |
| MSCI China | 25.660 HKD | +0.160 | +0.627% | 441.46K | 11.30M | 25.279 (+1.506%) HKD as at 2025/08/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 37.520 HKD | +1.140 | +3.134% | 281.80K | 10.57M | 36.114 (+3.893%) HKD as at 2025/08/01 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.860 HKD | -0.116 | -2.918% | 2.59M | 10.02M | 4.019 (-3.961%) HKD as at 2025/08/01 | | |
| Hang Seng High Dividend Yield | 29.740 HKD | +0.240 | +0.814% | 277.21K | 8.22M | 29.378 (+1.231%) HKD as at 2025/08/01 | | |
| CSI 300 | 46.140 HKD | +0.220 | +0.479% | 157.71K | 7.26M | 46.030 (+0.239%) HKD as at 2025/08/04 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.755 HKD | +0.240 | +2.819% | 760.10K | 6.70M | 8.509 (+2.886%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.220 HKD | +0.200 | +1.175% | 375.30K | 6.48M | 16.941 (+1.647%) HKD as at 2025/08/01 | | |
| FTSE China A50 | 13.760 HKD | +0.010 | +0.073% | 360.74K | 4.96M | 13.711 (+0.360%) HKD as at 2025/08/04 | | |
| NASDAQ-100 Index | 445.100 HKD | +6.300 | +1.436% | 10.60K | 4.72M | 435.681 (+2.162%) HKD as at 2025/08/01 | | |
| CSI 300 | 42.200 CNY | +0.200 | +0.476% | 111.60K | 4.70M | 42.103 (+0.230%) CNY as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.590 HKD | -0.017 | -2.801% | 7.74M | 4.57M | 0.615 (-4.003%) HKD as at 2025/08/01 | | |
| Hong Kong Interbank Offered Rate | 1,160.000 HKD | -0.150 | -0.013% | 3.80K | 4.41M | 1,160.421 (-0.036%) HKD as at 2025/08/04 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.620 HKD | -0.050 | -0.517% | 457.30K | 4.40M | 9.711 (-0.940%) HKD as at 2025/08/04 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.150 HKD | -0.040 | -0.282% | 280.20K | 3.98M | 14.168 (-0.125%) HKD as at 2025/08/04 | | |
| CME Ether Futures | 17.260 HKD | +0.460 | +2.738% | 201.90K | 3.51M | 16.630 (+3.787%) HKD as at 2025/08/01 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.885 HKD | +0.015 | +0.152% | 315.61K | 3.12M | 9.781 (+1.066%) HKD as at 2025/08/04 | | |